FDA Adverse Event Malfunction Summary report: N

TRUEMETRIX

MDR report key: 8270466 · Received January 23, 2019

Report

Report Number
1000113657-2019-00056
Event Type
Malfunction
Date Received
January 23, 2019
Date of Event
December 27, 2018
Report Date
January 24, 2019
Manufacturer
TRIVIDIA HEALTH, INC.
Product Code
NBW
UDI-DI
00021292007836
PMA / PMN Number
K140100
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(MANUFACTURER NARRATIVE = T, CORRECTED DATA = T) INTERNAL REPORT # 01611468 RETURNED METER EVALUATED WITH NO DEFECT FOUND. TEST STRIPS NOT RETURNED FOR EVALUATION. MOST LIKELY UNDERLYING ROOT CAUSE: MLC-58-USER HAD AN INACCURATE REFERENCE: SELF: THE PERSON IS USING THEMSELVES AS THE REFERENCE OR HOW THEY FEEL AT THE TIME THEY RUN THE BLOOD TEST. TEST STRIP UDI#: (B)(4). NOTE: UNABLE TO CONTACT THE CUSTOMER VIA TELEPHONE AT CALL BACKS ON 01/03/2019, 01/07/2019 AND 01/10/2019. PRODUCT NOTIFICATION LETTER SENT TO CUSTOMER TO CONTACT CUSTOMER CARE.

Description of Event or Problem · 0

CONSUMER REPORTED COMPLAINT FOR HIGH AND ERRATIC BLOOD GLUCOSE TEST RESULTS. THE CUSTOMER IS CONCERNED WITH TESTS RESULTS FROM BACK TO BACK BLOOD TESTS OF 232, 190 AND 212 MG/DL. THE CUSTOMER'S EXPECTED FASTING BLOOD GLUCOSE TEST RESULT RANGE IS 170 - 205 MG/DL. CUSTOMER WAS USING CORRECT TESTING TECHNIQUE. AT THE TIME OF THE CALL THE CUSTOMER REPORTED FEELING SHAKY AND NAUSEOUS. CUSTOMER WAS GOING TO CONTACT HER PHYSICIAN. DURING THE CALL ON 12/27/2018, A BACK TO BACK BLOOD TEST WAS NOT PERFORMED BY THE CUSTOMER. THE PRODUCT IS STORED ACCORDING TO SPECIFICATION IN THE BEDROOM. THE TEST STRIP LOT MANUFACTURER'S EXPIRATION DATE IS 05/23/2020 AND OPEN VIAL DATE IS 12/25/2018. THE METER MEMORY WAS REVIEWED FOR PREVIOUS TEST RESULT HISTORY: RESULT 1:232MG/DL, (B)(6), 10:54AM, FASTING; RESULT 2:190MG/DL, (B)(6), 10:40AM, FASTING; RESULT 3:212MG/DL, (B)(6), 10:39AM, FASTING; RESULT 4:185MG/DL, (B)(6), 9:28AM, FASTING.

Additional Manufacturer Narrative · 1

(B)(4). RETURNED METER EVALUATED WITH NO DEFECT FOUND. TEST STRIPS NOT RETURNED FOR EVALUATION. MOST LIKELY UNDERLYING ROOT CAUSE: MLC-58-USER HAD AN INACCURATE REFERENCE: LAB RESULTS: THE END USER IS COMPARING RESULTS OBTAINED FROM TRIVIDIAS'S BGM SYSTEM TO THE RESULTS FROM THE LABORATORY. (B)(4). UNABLE TO CONTACT THE CUSTOMER VIA TELEPHONE AT CALL BACKS ON (B)(4) 2019. PRODUCT NOTIFICATION LETTER SENT TO CUSTOMER TO CONTACT CUSTOMER CARE.

Description of Event or Problem · 1

CONSUMER REPORTED COMPLAINT FOR HIGH AND ERRATIC BLOOD GLUCOSE TEST RESULTS. THE CUSTOMER IS CONCERNED WITH TESTS RESULTS FROM BACK TO BACK BLOOD TESTS OF 232, 190 AND 212 MG/DL. THE CUSTOMER'S EXPECTED FASTING BLOOD GLUCOSE TEST RESULT RANGE IS 170 - 205 MG/DL. CUSTOMER WAS USING CORRECT TESTING TECHNIQUE. AT THE TIME OF THE CALL THE CUSTOMER REPORTED FEELING SHAKY AND NAUSEOUS. CUSTOMER WAS GOING TO CONTACT HER PHYSICIAN. DURING THE CALL ON (B)(6) 2018, A BACK TO BACK BLOOD TEST WAS NOT PERFORMED BY THE CUSTOMER. THE PRODUCT IS STORED ACCORDING TO SPECIFICATION IN THE BEDROOM. THE TEST STRIP LOT MANUFACTURER'S EXPIRATION DATE IS 05/23/2020 AND OPEN VIAL DATE IS (B)(6) 2018. THE METER MEMORY WAS REVIEWED FOR PREVIOUS TEST RESULT HISTORY: (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
63423 TRUEMETRIX BLOOD GLUCOSE SYSTEM NBW TRIVIDIA HEALTH, INC. TRUEMETRIX MV3015 00021292007836

Patients

Seq Age Sex Outcome Treatment
1 0 YR SECOND THERAPY| SECOND THERAPY| SECOND THERAPY